跳至主要内容
临床试验/NCT07446088
NCT07446088招募中不适用

A Single-center, Open-label, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of a Statics Electricity Generator for Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation

Ceragem Clinical Inc.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Change and percent change in blood flow of the dorsal metacarpal vein

研究概览

简要总结

This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.

详细描述

This clinical trial is conducted to evaluate the efficacy and safety of the personal electro-potential generator, CGM MEPC-2401, on the improvement of blood circulation in healthy adult subjects by applying the investigational medical device, the Ceragem Celtron Circulation Chair (CGM MEPC-2401).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged between 19 and 65 years
  • Individuals with a BMI of 30.0 kg/m² or less
  • Individuals without abnormal findings on hematology tests (CBC)

排除标准

  • Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest)
  • Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.)
  • Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions
  • Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)

研究组 & 干预措施

CGM MEPC-2401

Experimental

干预措施: CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401) (Device)

结局指标

主要结局

Change and percent change in blood flow of the dorsal metacarpal vein

时间窗: from baseline to immediately after a 30-minute application of the investigational device

Change and percent change in blood flow of the dorsal metacarpal vein from baseline to immediately after a 30-minute application of the investigational device

次要结局

  • Change and percent change in capillary diameter assessed by capillary microscopy(from baseline to immediately after a 30-minute application of the investigational device (total duration: 30 minutes))
  • Change and percent change in oxygen saturation (SpO₂)(from baseline to immediately after a 30-minute application of the investigational device (total duration: 30 minutes))
  • Change and percent change in blood zeta potential, cellular ATP levels, nitric oxide, membrane potential, and matrix metalloproteinases(from baseline to immediately after a 30-minute application of the investigational device (total duration: 30 minutes))

研究者

发起方
Ceragem Clinical Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验